These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 22387278

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy.
    Seguin J, Brullé L, Boyer R, Lu YM, Ramos Romano M, Touil YS, Scherman D, Bessodes M, Mignet N, Chabot GG.
    Int J Pharm; 2013 Feb 28; 444(1-2):146-54. PubMed ID: 23380621
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M.
    Eur J Pharm Biopharm; 2007 May 28; 66(2):227-43. PubMed ID: 17127045
    [Abstract] [Full Text] [Related]

  • 6. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C, Wang C, Yang H, Zhao X, Wei N, Cui J.
    J Pharm Pharmacol; 2012 Mar 28; 64(3):372-82. PubMed ID: 22309269
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.
    Touil YS, Seguin J, Scherman D, Chabot GG.
    Cancer Chemother Pharmacol; 2011 Aug 28; 68(2):445-55. PubMed ID: 21069336
    [Abstract] [Full Text] [Related]

  • 11. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
    Parveen R, Baboota S, Ali J, Ahuja A, Vasudev SS, Ahmad S.
    Int J Pharm; 2011 Jul 15; 413(1-2):245-53. PubMed ID: 21549187
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
    Nornoo AO, Osborne DW, Chow DS.
    Int J Pharm; 2008 Feb 12; 349(1-2):108-16. PubMed ID: 17869459
    [Abstract] [Full Text] [Related]

  • 14. Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification.
    Oh DH, Balakrishnan P, Oh YK, Kim DD, Yong CS, Choi HG.
    Int J Pharm; 2011 Feb 14; 404(1-2):191-7. PubMed ID: 21055456
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite.
    Touil YS, Auzeil N, Boulinguez F, Saighi H, Regazzetti A, Scherman D, Chabot GG.
    Biochem Pharmacol; 2011 Dec 01; 82(11):1731-9. PubMed ID: 21840301
    [Abstract] [Full Text] [Related]

  • 17. Self-nanoemulsifying drug delivery system of persimmon leaf extract: Optimization and bioavailability studies.
    Li W, Yi S, Wang Z, Chen S, Xin S, Xie J, Zhao C.
    Int J Pharm; 2011 Nov 25; 420(1):161-71. PubMed ID: 21884770
    [Abstract] [Full Text] [Related]

  • 18. Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment.
    Bali V, Ali M, Ali J.
    Int J Pharm; 2011 Jan 17; 403(1-2):46-56. PubMed ID: 20969935
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.